Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 605

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 605
---
, 2023, no dividends have been declared or paid by the Company.

| F-85 |

aegeria soft tissue llc

notes to the financial statements

December 31, 2023 and 2022

Voting rights

Each holder of a preferred stock is entitled to the number of votes equal to the number of shares of common stock into which the shares of preferred stock held by such holder could be converted as of the record date.

Redemption

The Series A Preferred units are non-redeemable.

Conversion rights

The holders of the Series A Preferred units may convert their units into common units on a 1:1 basis at any time. The Series A Preferred units will automatically be converted into common units (i) if the holders of at least a majority of the outstanding Series A Preferred units consent to such conversion or (ii) upon the closing of a firmly underwritten public offering of shares of common units of the Company at a price per share not less than two times the original purchase price of the Series A Preferred Units.

Liquidation preference

The Series A Preferred units contain the following liquidation preferences:

| ● | First,                                                                                         
 prior to any distribution to other classes of unitholders, the Series A Preferred unitholders  
 are entitled to receive their original purchase price.                                         |
| ● | Second,                                                                                        
 on an if converted basis, equally with common unitholders up to a total 1.5 times the original 
 purchase price of the Series A Preferred Units.                                                |

A merger, acquisition or sale of substantially all of the assets Company including a units for units or stock exchange shall be deemed to be a liquidation or winding up for purposes of the liquidation preference, unless waived by the holders of a majority of the Series A Preferred units.

Anti-dilution rights

The conversion price of the Series A Preferred units shall be subject to adjustment, on a broad-based weighted average basis to prevent dilution if the Company issues additional equity securities at a purchase price per share less than the then current applicable conversion price. There will be no adjustment to the conversion price for issuance of (i) common units upon conversion of Series A Preferred units, (iii) units issued to employees, consultants, or directors in accordance with plans approved by the board of directors, and (iii) common units issued to JHU pursuant to the license agreement between JHU and the Company.

| F-86 |

aegeria soft tissue llc

notes to the financial statements

December 31,